Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Hamsyl 3750 IU Injection
Manufacturer/Marketed By : Emcure Pharmaceuticals Ltd
$615.37 $551.14
Hamsyl 3750 IU Injection is an effective anti-cancer therapy designed to combat various hematological malignancies, including different forms of blood cancer and Hodgkin's lymphoma. This medication works by inhibiting the...
Pegaspargase 3750 IU
Active Pharmaceutical Ingredient
Hamsyl 3750 IU Injection
$615.37
$551.14
Hamsyl 3750 IU Injection is an effective anti-cancer therapy designed to combat various hematological malignancies, including different forms of blood cancer and Hodgkin's lymphoma. This medication works by inhibiting the growth of cancer cells, helping to control the spread of the disease when used alone or in conjunction with other chemotherapy agents. Patients receiving Hamsyl should be monitored closely due to potential side effects such as low blood cell counts and increased susceptibility to infections. It is essential to discuss any pre-existing health conditions or ongoing medications with your healthcare provider before starting treatment, as this can influence the efficacy and safety of Hamsyl. As part of a comprehensive cancer treatment plan, Hamsyl 3750 IU Injection offers hope for patients aiming to achieve remission and improve their overall quality of life. Always adhere to your healthcare professional's guidance regarding dosage and administration to ensure the best possible outcomes. With ongoing medical advancements, Hamsyl remains a vital option in the fight against cancer, demonstrating its role in modern oncology.
Active Pharmaceutical Ingredient
Uses
• Hamsyl 3750 iu injection is commonly utilized in the treatment of Acute Lymphoblastic Leukemia (ALL). This medication plays a crucial role in the management of this aggressive form of cancer, helping to control the proliferation of abnormal lymphoid cells. By effectively targeting these cells, Hamsyl 3750 iu injection aids in improving patient outcomes. It is often part of a comprehensive treatment regimen.
• Another important application of Hamsyl 3750 iu injection is in the management of Non-Hodgkin's Lymphoma (NHL). This type of cancer affects the lymphatic system and can vary widely in its behavior and prognosis. Hamsyl 3750 iu injection contributes to the therapeutic approach by helping to reduce tumor burden and enhance patient quality of life. It is typically administered in conjunction with other therapies for optimal effectiveness.
• Hamsyl 3750 iu injection is beneficial for patients experiencing hematological malignancies, particularly when rapid and effective intervention is needed. Its mechanism helps to regulate the growth of malignant cells, allowing for better control of the disease. In clinical settings, Hamsyl 3750 iu injection is often chosen for its efficacy in challenging cases. This makes it a valuable option in the oncological treatment landscape.
• In certain situations, Hamsyl 3750 iu injection may also be used in combination with other agents to enhance overall treatment efficacy. This synergistic approach can be crucial for patients with complex hematological conditions. Hamsyl 3750 iu injection not only helps in direct tumor management but also supports the overall therapeutic strategy. Its versatility makes it a significant component in the fight against lymphatic cancers.
Benefits
In blood cancer (acute lymphoblastic leukemia): Blood cancer, also known as leukemia, is a cancer of the tissues that make up blood, which reduces the body's ability to fight infection. Anti-cancer Drug Hamsyl works by killing or stopping the growth of cancer cells and also by preventing the cancer cells from multiplying. It is an effective but very toxic medicine, and you should discuss with your doctor the risks and benefits of this medicine. It would help if you drank plenty of water to stay hydrated and avoided alcohol while receiving this treatment. Hodgkin's disease: Hodgkin's disease is a form of lymphoma, a blood cancer that starts in the lymph system. The lymph system helps the immune system remove waste and fight infection. Hamsyl 3750 IU works by killing or stopping the growth of cancer cells and preventing cancer cells from multiplying. Follow your doctor's instructions carefully, and tell your doctor or health care professional if any of the side effects bother you.
Side Effects
Like all medicines, Hamsyl 3750 IU Injection may cause side effects that do not require medical attention and that will disappear as your body adjusts to the medicine. Tell your doctor if they persist or if you're worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Weakness
• Loss of appetite
• Diarrhoea
• Epigastric pain
• Swelling over hands/ feet and ankles
• Injection site reaction ( like pain, redness, swelling)
• Irritability
Common Side Effects
• Drowsiness
• Acute Pancreatitis ( Pain in abdomen, unable to eat, swollen and tender abdomen, Rapid pulse)
• Headache
• Tiredness
• Irritability
• Stomach cramps
• Weight loss
How To Use
Hamsyl 3750 IU Injection is available in liquid (injectable) IM and IV forms, which should be administered by a healthcare professional under medical supervision. The dosage and frequency of administration will be determined by your physician based on your medical condition and a number of other factors.
Safety Advice
• Alcohol: Drinking alcohol while taking Hamsyl 3750 IU is generally not recommended. It may increase the risk of liver damage and it is best to avoid alcohol or to limit the amount of alcohol you drink while you are taking this medicine.
• Kidney: Patients with kidney disease should use Pegaspargase Injection 3750 IU with caution. It is important that patients with kidney disease monitor their kidney function closely while taking Hamsyl 3750 IU and report any unusual symptoms or changes in kidney function to their doctor or health care professional. The dose of Hamsyl 3750 IU Injection may need to be adjusted in patients with kidney disease.
• Breastfeeding: There are no data on the presence of Hamsyl 3750 IU or its metabolites in human milk or effects on nursing infants or lactation. Because of the potential for serious adverse reactions in nursing infants, women should be advised not to breastfeed during treatment with Hamsyl Injection and for 2 weeks after the last dose.
• Liver: The use of Hamsyl 3750 IU Injection should be used with caution in patients with liver disease. It is important that patients with liver disease monitor their liver function closely while taking Hamsyl 3750 IU and report any unusual symptoms or changes in liver function to their doctor or health care professional. In such patients with liver disease, the dose may need to be adjusted by your doctor.
• Pregnancy: The use of Hamsyl 3750 IU Injection is not recommended in pregnant women as it may cause harm to the foetus if administered to a pregnant woman.
• Driving: Hamsyl 3750 IU Injection does not alter or impair the ability to drive or use machines.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.